oncology Biliary Tract Cancer: Expert Review and Commentary from Published Literature Dr. Vincent Tam A Promise for Change in First-line Standard of Care for Biliary Tract Cancer Download 4 PowerPoint slides
rheumatology GRAPPA Annual Meeting and Trainee Symposium 2022 July 14-16, 2022 — Brooklyn, New York Advancements in Psoriatic Arthritis Management: Updated GRAPPA Treatment Recommendations Download 1 PowerPoint slides
neurology 8th Congress of the European Academy of Neurology (EAN) 2022: Expert Interview Dr. Jonathan P. Gladstone — Length: 10:42 Stepping Up Preventive Migraine Therapy: New Lessons from Head-To-Head Trial Watch Presentation
neurology 8th Congress of the European Academy of Neurology (EAN) 2022 June 25-28, 2022 — Vienna, Austria Head-to-Head Trial Supports Early CGRP Inhibitor Treatment in Poorly Controlled Migraine Download 4 PowerPoint slides
neurology 8th Congress of the European Academy of Neurology (EAN) 2022: Expert Interview Dr. Daniel Selchen — Length: 05:28 Optimizing Treatment in SPMS to Target Disability Progression and Cognitive Impairment Watch Presentation
neurology 8th Congress of the European Academy of Neurology (EAN) 2022 June 25-28, 2022 — Vienna, Austria Therapy for SPMS Demonstrates Protection from Physical Disability Progression and Cognitive Impairment Download 5 PowerPoint slides
Infectious Disease HIV: Expert Discussion Dr. Routy & Dr. Fraser — Length: 12:22 Personalized Treatment Approaches for HIV Management Watch Presentation
neurology 2022 Annual SMA Research & Clinical Care Meeting June 16-19, 2022 — Anaheim, California State of SMA Report Confirms Large Treatment-Related Improvements in Spinal Muscular Atrophy Outcomes Download 4 PowerPoint slides
Hematology 2022 European Hematology Association (EHA) Congress Dr. Carolyn Owen — Length: 05:14 Long-term ASPEN Data: Demonstrated Efficacy and Tolerability in Patients with Waldenström Macroglobulinemia Watch Presentation
neurology Medication Overuse Headache: eLearning Program Dr. Elizabeth Leroux — Length: 23:22 Targeting an Individualized Treatment Strategy for Patients with Medication Overuse Headache Watch Presentation
Hematology American Society of Clinical Oncology (ASCO) 2022 Annual Meeting Dr. Versha Banerji — Length: 04:15 Continued Benefit for First-line CLL Treatment: ELEVATE-TN 5-year Follow-up Watch Presentation
Hematology American Society of Clinical Oncology (ASCO) 2022 Annual Meeting June 3-7, 2022 — Chicago, Illinois ELEVATE-TN: At 5 Years, Progression-free Survival with High Tolerability Maintained in Treatment-naïve CLL Patients Download 4 PowerPoint slides
